Twinbeech Capital LP Novo Cure LTD Transaction History

Twinbeech Capital LP

$4.99 Billion
Q3 2024

A detailed history of Twinbeech Capital LP transactions in Novo Cure LTD stock. As of the latest transaction made, Twinbeech Capital LP holds 198,395 shares of NVCR stock, worth $6.11 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

198,395

Previous 125,128 58.55%

Holding current value

$6.11 Million

Previous $2.14 Million 44.66%

% of portfolio

0.06%

Previous 0.04%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$15.61 - $23.34 $1.14 Million - $1.71 Million	73,267 Added 58.55%	198,395 $3.1 Million
Q2 2024 Aug 14, 2024	SELL	$11.83 - $24.05 $45,356 - $92,207	-3,834 Reduced 2.97%	125,128 $2.14 Million
Q1 2024 May 15, 2024	SELL	$12.42 - $17.29 $601,612 - $837,510	-48,439 Reduced 27.3%	128,962 $2.02 Million
Q4 2023 Feb 14, 2024	SELL	$11.13 - $15.78 $2.83 Million - $4.02 Million	-254,512 Reduced 58.93%	177,401 $2.65 Million
Q3 2023 Nov 14, 2023	BUY	$16.15 - $42.35 $2.37 Million - $6.21 Million	146,737 Added 51.45%	431,913 $6.98 Million
Q2 2023 Aug 14, 2023	BUY	$40.29 - $82.51 $8.14 Million - $16.7 Million	201,975 Added 242.76%	285,176 $11.8 Million
Q1 2023 May 15, 2023	BUY	$56.44 - $118.81 $4.7 Million - $9.89 Million	83,201 New	83,201 $5 Million
Q2 2022 Aug 15, 2022	SELL	$56.6 - $89.9 $449,234 - $713,536	-7,937 Reduced 72.48%	3,014 $209,000
Q1 2022 May 16, 2022	SELL	$60.15 - $84.52 $2.48 Million - $3.48 Million	-41,196 Reduced 79.0%	10,951 $907,000
Q4 2021 Feb 14, 2022	BUY	$75.08 - $121.99 $3.92 Million - $6.36 Million	52,147 New	52,147 $3.92 Million
Q2 2020 Aug 14, 2020	SELL	$57.2 - $74.41 $1.33 Million - $1.73 Million	-23,266 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$57.05 - $95.75 $1.06 Million - $1.78 Million	18,565 Added 394.92%	23,266 $1.57 Million
Q4 2019 Feb 14, 2020	BUY	$68.3 - $93.8 $321,078 - $440,953	4,701 New	4,701 $396,000

Others Institutions Holding NVCR

# of Institutions

263

Shares Held

77M

Call Options Held

1.17M

Put Options Held

318K

View Full List

About NovoCure Ltd

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $3.23B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

More about NVCR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Twinbeech Capital LP, based on Form 13F filings with the SEC.

News

Stay updated on Twinbeech Capital LP with notifications on news.

Account

Twinbeech Capital LP Novo Cure LTD Transaction History